P. Knudsen et al., HETEROZYGOUS HEPATIC LIPASE DEFICIENCY, DUE TO 2 MISSENSE MUTATIONS R186H AND L334F, IN THE HL GENE, Atherosclerosis, 128(2), 1997, pp. 165-174
Hepatic lipase (HL) is an endothelial enzyme involved in the metabolis
m of intermediate density lipoproteins (IDL) and high density lipoprot
eins (HDL) in plasma. In a Finnish pedigree consisting of Is members b
elonging to three generations two missense mutations RI86H and L334F i
n exons 5 and 7 of the HL gene co-segregated with low post-heparin HL
activity. Haplotype analysis of the HL gene in family members revealed
a high degree of genetic variation and demonstrated that the two miss
ense mutations reside on the same chromosome. In vitro site-directed m
utagenesis and expression of the cDNA constructs in COS-I cells reveal
ed that the R186H mutation leads to a protein that is not secreted whi
le the L334F mutation results in the production of a HL protein that i
s secreted but has only about 30% of wild type HL activity. Carriers o
f the mutated HL gene exhibited clearly reduced HL activity and mass i
n post-heparin plasma. Probably due to their heterozygous carrier stat
us they had only moderate elevation of total triglycerides, IDL, and L
DL-triglycerides. The LDL-particles were enriched in triglycerides and
depleted of cholesterol. Also their HDL2- and HDL3-particles were enr
iched in triglycerides. (C) 1997 Elsevier Science Ireland Ltd.